Business Description
Medicofarma Biotech SA
ISIN : PLINBOK00010
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.7 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.32 | |||||
Beneish M-Score | 16.15 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -48.8 | |||||
3-Year EPS without NRI Growth Rate | 24.8 | |||||
3-Year FCF Growth Rate | 58.5 | |||||
3-Year Book Growth Rate | 22.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.09 | |||||
9-Day RSI | 15.24 | |||||
14-Day RSI | 22.98 | |||||
6-1 Month Momentum % | -12.39 | |||||
12-1 Month Momentum % | -1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.52 | |||||
Days Sales Outstanding | 113.12 | |||||
Days Payable | 1856.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -115.6 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.52 | |||||
Operating Margin % | -159.28 | |||||
Net Margin % | -162.12 | |||||
FCF Margin % | -131.81 | |||||
ROE % | -16.44 | |||||
ROA % | -12.3 | |||||
ROIC % | -11.7 | |||||
ROC (Joel Greenblatt) % | -15.55 | |||||
ROCE % | -16.15 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 44.63 | |||||
PB Ratio | 5.23 | |||||
Price-to-Tangible-Book | 6.06 | |||||
EV-to-EBIT | -30.09 | |||||
EV-to-EBITDA | 1599.11 | |||||
EV-to-Revenue | 47.93 | |||||
EV-to-FCF | -36.37 | |||||
Price-to-Median-PS-Value | 42.4 | |||||
Earnings Yield (Greenblatt) % | -3.32 | |||||
FCF Yield % | -2.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medicofarma Biotech SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 1.201 | ||
EPS (TTM) (zł) | -0.03 | ||
Beta | 0.24 | ||
Volatility % | 38.13 | ||
14-Day RSI | 22.98 | ||
14-Day ATR (zł) | 0.033649 | ||
20-Day SMA (zł) | 0.9387 | ||
12-1 Month Momentum % | -1 | ||
52-Week Range (zł) | 0.81 - 2 | ||
Shares Outstanding (Mil) | 67.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medicofarma Biotech SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medicofarma Biotech SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Medicofarma Biotech SA Frequently Asked Questions
What is Medicofarma Biotech SA(WAR:MDB)'s stock price today?
When is next earnings date of Medicofarma Biotech SA(WAR:MDB)?
Does Medicofarma Biotech SA(WAR:MDB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |